sb 216763 has been researched along with Colonic Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bar-Yehuda, S; Barer, F; Erlanger, A; Fishman, P; Madi, L; Ochaion, A; Ohana, G | 1 |
Bruyneel, E; Dale, T; De Wever, O; Gespach, C; Le Floch, N; Mareel, M; Rivat, C | 1 |
Altieri, DC; Ghosh, JC | 1 |
Evers, BM; Wang, Q; Wang, X; Zhou, Y | 1 |
4 other study(ies) available for sb 216763 and Colonic Neoplasms
Article | Year |
---|---|
An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.
Topics: Adenosine; Animals; beta Catenin; Carcinoma; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Cyclic AMP-Dependent Protein Kinases; Cyclin D1; Cytoskeletal Proteins; Down-Regulation; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Growth Inhibitors; Humans; Indoles; Lithium; Maleimides; Mice; Mice, Nude; NF-kappa B; Proto-Oncogene Proteins c-myc; Purinergic P1 Receptor Agonists; Pyridines; Trans-Activators | 2004 |
The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling.
Topics: Animals; Antibodies, Monoclonal; Axin Protein; Cell Line; Cell Line, Transformed; Cell Line, Tumor; Colonic Neoplasms; Colorectal Neoplasms; Dogs; Epithelial Cells; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Glycoproteins; Heterotrimeric GTP-Binding Proteins; HT29 Cells; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Neoplasms; Ligands; Lithium Chloride; Maleimides; Matrix Metalloproteinase 7; Neoplasm Invasiveness; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Repressor Proteins; Retroviridae; Signal Transduction; Transcription Factor AP-1; Transcription, Genetic; Wnt Proteins; Wnt2 Protein | 2005 |
Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Topics: Apoptosis; beta Catenin; Blotting, Western; CDC2 Protein Kinase; Cell Cycle Proteins; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cytoskeletal Proteins; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HCT116 Cells; Humans; Indoles; Inhibitor of Apoptosis Proteins; Maleimides; Microtubule-Associated Proteins; Mutation; Neoplasm Proteins; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Purines; RNA Interference; Survivin; TCF Transcription Factors; Thiadiazoles; Trans-Activators; Transcription Factor 7-Like 2 Protein; Transcription Factors; Transfection; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2005 |
Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.
Topics: Apoptosis; Blotting, Northern; Blotting, Western; Caco-2 Cells; Cell Differentiation; Cell Line; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Humans; Indoles; Interleukin-8; Luciferases; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Protein Kinase C-delta; Ribonucleases; RNA; RNA Interference; RNA, Small Interfering; Signal Transduction; Time Factors; Transfection | 2006 |